References
Knox JJ, Puodziunas ALV, Feld R. Chemotherapy-induced oral mucositis: prevention and management. Drugs Aging 2000 Oct; 17(4): 257–67
Woo SB, Sonis ST, Monopoli MM, et al. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer 1993; 72: 1612–7
Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 1998; 34: 39–43
McCarthy GM, Awde JD, Gtardi H, et al. Risk factors associated with mucositis in cancer patients receiving 5-FU. Oral Oncol 1998; 34: 484–90
Wadleigh RG, Redman RS, Graham ML, et al. Vitamin E in the treatment of chemotherapy-induced mucositis. Am J Med 1992; 92: 481–4
Duenas-Gonzalez A, Sobrevilla-Calvo P, Frias-Medivil M, et al. Misoprostol prophylaxis for high-dose chemotherapy-induced mucositis: a randomized double-blind study. Bone Marrow Transplant 1996; 17: 809–12
Labar B, Mrsic M, Pavletic Z, et al. Prostaglandin E2 for prophylaxis of oral mucositis following BMT. Bone Marrow Transplant 1993; 11: 379–82
Levi F, Zidani R, Missel JL. Randomized multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. Lancet 1997; 350: 681–6
Loprinzi CL, Dose AM. Studies on the prevention of 5-fluorouracil-induced oral mucositis. NCI Monogr 1990; 9: 93–4
Ahmed T, Engelking C, Szalyga J, et al. Propantheline prevention of mucositis from etoposide. Bone Marrow Transplant 1993; 12: 131–2
Mahood DJ, Dose AM, Loprinzi CL, et al. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol 1991; 9: 449–52
Rocke LK, Loprinzi CL, Lee JK, et al. A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil related stomatitis. Cancer 1993; 72: 2234–8
Sonis S, Muska A, O’Brien J, et al. Alteration in the frequency, severity and duration of chemotherapy-induced mucositis in hamsters by interleukin-11. Eur J Cancer B Oral Oncol 1996; 31B: 261–6
Spijkervet F, Sonis S. New frontiers in the management of chemotherapy- induced mucositis. Curr Opin Oncol 1998; 10 Suppl. 1: 523–7
Danilenko D. Pre-clinical and early clinical development of keratinocyte growth-factor. Toxicol Pathol 1999; 27(1): 64–71
Feld R. The role of surveillance cultures in patients likely to develop chemotherapy-induced mucositis. Support Care Cancer 1997; 5: 371–5
Rights and permissions
About this article
Cite this article
Simple measures most effective for chemotherapy-induced oral mucositis. Drugs Ther. Perspect 17, 8–11 (2001). https://doi.org/10.2165/00042310-200117230-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200117230-00003